Petmed Story

<div class='circular--portrait' style='background:#4E8BFC;color: #ffffff;font-size:4em;'>PE</div>
PETS -- USA Stock  

USD 33.50  1.50  4.69%

Let's first try to sum up why PetMed Express investors are seeking stability amid unprecedented economic uncertainty. PetMed Express is at this time traded for 1.05. The entity has historical hype elasticity of -0.59. The average price elasticity to hype of competition is about -0.11. The firm is projected to decline in value after the next press release, with the price expected to drop to 34.14. The average volatility of headline impact on the company stock price is huge, making predictions on the news or social media along less reliable. The price decrease on the next news is expected to be -1.7%, whereas the daily expected return is at this time at -1.34 percent. Given the investment horizon of 30 days the next projected announcement will be in about 4 days.
Published over a month ago
View all stories for Petmed Express | View All Stories
Thinking to buy more of PetMed Express (NASDAQ:PETS)?
The company holds a Beta of 0.691, which implies possible diversification benefits within a given portfolio. Let's try to break down what PetMed's beta means in this case. As returns on the market increase, PetMed Express returns are expected to increase less than the market. However, during the bear market, the loss on holding PetMed Express will be expected to be smaller as well. Even though it is essential to pay attention to PetMed Express current trending patterns, it is always good to be careful when utilizing equity existing price patterns. Our philosophy towards forecasting any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. PetMed Express exposes twenty-one different technical indicators, which can help you to evaluate its performance. PetMed Express has an expected return of -1.34%. Please be advised to check PetMed Express jensen alpha and semi variance to decide if PetMed Express stock performance from the past will be repeated at some point in the near future.
The successful prediction of Petmed Express stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Petmed Express, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Petmed Express based on Petmed Express hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Petmed Express's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Petmed Express's related companies.

Use Technical Analysis to project Petmed expected Price

Petmed Express technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Petmed Express technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Petmed Express trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

How Petmed utilizes its cash?

To perform a cash flow analysis of Petmed Express, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Petmed Express is receiving and how much cash it distributes out in a given period. The Petmed Express cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Petmed Express Net Cash Flow from Operations is relatively stable at the moment as compared to the past year. Petmed Express reported last year Net Cash Flow from Operations of 34.96 Million

Detailed Perspective On Petmed Express

The big decline in price over the last few months for PetMed Expressmay encourage retail investors to take a closer look at the company as it is trading at a share price of 1.05 on very low momentum in trading volume. The company directors and management failed to add value to investors and positioning the company supply of money to exploit market volatility in December. However, diversifying your holdings with PetMed Express or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 30 days investing horizon is currently 12.47. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the PetMed Express partners.

Cost of Revenue Breakdown

PetMed Express Cost of Revenue yearly trend continues to be relatively stable with very little volatility. Cost of Revenue is likely to drop to about 206.7 M. Cost of Revenue usually refers to the aggregate cost of goods produced and sold and services rendered during the reporting period. PetMed Express Cost of Revenue is relatively stable at the moment as compared to the past year. PetMed Express reported last year Cost of Revenue of 216.32 Million
2013
2014
2015
2016
2017
2018
2020
2021
2013155.77 Million
2014153.12 Million
2015158.39 Million
2016169.86 Million
2017175.99 Million
2018188.1 Million
2020216.32 Million
2021206.72 Million

Time to pull out from PetMed Express is now

The jensen alpha is down to -1.4 as of today. As of the 18th of January 2021, PetMed Express holds the risk adjusted performance of (0.1), and Coefficient Of Variation of (941.33). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of PetMed Express, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for PetMed Express, which can be compared to its competitors. Please check PetMed Express jensen alpha and semi variance to decide if PetMed Express is priced some-what accurately, providing market reflects its current price of 1.05 per share. Given that PetMed Express is a hitting penny stock territory we advise to closely look at its total risk alpha.

Our Takeaway on PetMed Express Investment

While many other companies in the pharmaceutical retailers industry are either recovering or due for a correction, PetMed Express may not be performing as strong as the other in terms of long-term growth potentials. The bottom line, as of the 18th of January 2021, our research shows that PetMed Express is a rather somewhat reliable investment opportunity with a low probability of distress in the next two years. From a slightly different view, the entity currently appears to be fairly valued. Our primary 30 days recommendation on the enterprise is Hold.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Petmed Express. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com